Beam Therapeutics Cash Flow Statement (2019-2026) | BEAM

Cash Flow Statement Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
-59.03M-28.12M-64.71M-75.58M-79.91M-84.08M-38.36M-88.97M-82.78M-96.09M142.76M-92.28M-91.05M-96.67M-90.35M-109.42M-102.29M-112.73M244.30M-97.35M
Depreciation and Depletion (Quarter)
1.59M1.68M2.56M3.26M3.42M3.47M3.94M4.65M4.82M5.19M5.36M5.43M5.58M5.47M5.44M5.53M5.54M5.56M5.67M5.61M
Share-based Compensation (Quarter)
10.45M12.97M15.50M18.04M21.58M22.21M22.50M23.92M26.28M25.84M22.62M29.28M31.60M29.56M30.22M26.68M24.37M22.75M20.45M19.04M
Gains from Sales and Divestitures (Quarter)
0.60M0.80M1.02M0.28M0.32M0.38M0.42M0.28M0.35M0.42M0.47M0.42M0.49M0.58M1.30M0.61M0.69M0.78M1.05M0.72M
Gains from Investment Securities (Quarter)
0.03M6.14M-24.23M7.26M30.80M0.25M0.13M8.83M2.25M-1.62M9.97M10.14M0.03M2.10M0.06M0.32M0.52M0.55M0.16M
Non-cash Items (Quarter)
1.73M107.30M300.56M2.60M3.01M3.42M110.99M3.91M152.50M136.20M51.65M5.08M5.77M97.60M37.18M109.60M95.70M84.20M7.38M7.57M
Cash from Operations (Quarter)
-32.53M3.01M1.83M218.49M-52.28M-74.50M-69.19M-109.81M-84.67M-89.78M135.07M-99.75M-83.01M-88.12M-76.36M-103.88M-76.45M-81.48M-83.29M-128.51M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
0.02M0.03M0.05M0.39M0.70M3.22M5.10M6.93M7.57M7.88M7.35M6.58M5.93M5.62M4.64M8.47M4.23M3.26M0.04M
Depreciation & Amortization (CF) (Quarter)
1.67M1.75M2.63M3.31M3.42M3.47M3.94M4.65M4.82M5.19M5.36M5.43M5.58M5.47M5.44M5.53M5.54M5.56M5.67M5.61M
Change in Working Capital
Change in Account Payables (Quarter)
1.05M-1.72M2.16M-1.25M0.10M0.62M2.90M-0.23M-2.53M-3.04M-1.77M1.28M1.77M-0.70M-0.55M3.79M2.64M-1.59M1.19M2.22M
Change in Accured Expenses (Quarter)
6.11M1.17M41.10M-16.53M3.40M3.94M8.44M-9.89M-0.27M7.42M70.40M-24.27M-19.49M-9.85M-4.08M-18.46M9.87M1.98M14.30M-16.26M
Investing Activities
Capital Expenditures (Quarter)
-7.05M29.01M-24.18M7.26M21.64M-23.25M43.29M10.68M11.52M7.95M3.59M0.36M0.16M5.46M-5.14M1.46M4.75M-3.08M-1.85M2.23M
Acquisitions (Quarter)
Change in Acquisitions & Divestments (Quarter)
142.07M260.39M106.35M160.31M350.57M333.64M360.09M298.00M365.52M271.43M-934.95M144.22M223.93M183.00M-551.14M217.15M166.67M240.64M-618.71M181.29M
Cash from Investing Activities (Quarter)
-13.14M76.11M-77.50M-537.34M-1.26M-36.17M113.44M25.45M-41.48M-10.23M98.10M-53.46M87.49M24.70M126.28M-125.09M-170.41M65.66M108.41M25.27M
Financing Activities
Other financing activities (Quarter)
0.52M0.21M0.13M0.01M0.10M0.03M0.05M0.06M0.18M0.38M0.81M
Debt Issuance and Repayment
Long-Term Debt Issuances (Quarter)
93.89M
Change in Capital Stock
Shares Issued (Quarter)
416.52M318.92M-727.58M1.41M0.05M0.50M106.29M93.98M-92.27M3.68M-2.35M1.40M1.22M-0.00M1.50M1.39M-2.89M1.51M
Preferred Shares Issued (Quarter)
Misc.
Cash from Financing Activities (Quarter)
160.44M320.89M21.54M55.68M22.34M1.56M32.01M98.42M107.54M36.78M33.71M2.90M0.13M1.26M3.44M473.38M1.11M1.68M1.89M96.61M
Change in Cash (Quarter)
114.77M400.01M-54.12M-263.17M-31.20M-109.11M76.26M14.05M-18.61M-63.24M266.88M-150.31M4.62M-62.16M53.36M244.41M-245.75M-14.15M27.00M-6.64M
Free Cash Flow (Quarter)
-25.48M-26.00M26.01M211.23M-73.92M-51.25M-112.48M-120.49M-96.19M-97.73M131.48M-100.11M-83.17M-93.58M-71.22M-105.34M-81.20M-78.40M-81.43M-130.75M
Net Cash Flow (Quarter)
114.77M400.01M-54.12M-263.17M-31.20M-109.11M76.26M14.05M-18.61M-63.24M266.88M-150.31M4.62M-62.16M53.36M244.41M-245.75M-14.15M27.00M-6.64M